ACHV Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (22 Apr 2024 @ 16:00):

Stats
Today's Volume	82 074.00
Average Volume	97 020.00
Market Cap	151.05M
EPS	$0 ( 2024-03-28 )
Next earnings date	( $-0.240 ) 2024-05-14
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.94
ATR14	$0.0110 (0.25%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-04	Stewart Richard Alistair	Buy	10 000	Common Stock
2024-03-04	Stewart Richard Alistair	Buy	10 000	Common Stock Warrants (right to buy)
2024-03-04	Bencich John	Buy	10 000	Common Stock
2024-03-04	Bencich John	Buy	10 000	Common Stock Warrants (right to buy)
2024-01-22	Martell Bridget A	Buy	31 500	Stock Option (right to buy)

INSIDER POWER
94.52
Last 96 transactions
Buy: 1 853 066 \| Sell: 57 073

Volume Correlation

Long: -0.04 (neutral)

Short: 1.00 (very strong)

Signal:(67.152) Expect same movement, but be aware

Achieve Life Sciences Inc Correlation

10 Most Positive Correlations
ESCA	0.963
EYEN	0.96
AGRX	0.954
NSTG	0.947
RCKY	0.947
OVID	0.945
CSPI	0.942
VOD	0.941
CNGL	0.94
AKU	0.938

10 Most Negative Correlations
PEAR	-0.958
VORB	-0.952
ADV	-0.937
BTWN	-0.934
NWLI	-0.934
AMZN	-0.934
DSEY	-0.933
PRSR	-0.931
RCMT	-0.931
PRSRU	-0.927

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Achieve Life Sciences Inc Correlation - Currency/Commodity

-0.38
( neutral )

-0.12
( neutral )

0.00
( neutral )

-0.65
( weak negative )

-0.11
( neutral )

-0.54
( weak negative )

Achieve Life Sciences Inc Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-228 000 (0.00 %)
EPS:	$-1.500

Q4	2023
Revenue:	$0
Gross Profit:	$-57 000.00 (0.00 %)
EPS:	$-0.260

Q3	2023
Revenue:	$0
Gross Profit:	$-100 000 (0.00 %)
EPS:	$-0.340

Q2	2023
Revenue:	$0
Gross Profit:	$-100 000 (0.00 %)
EPS:	$-0.430

Financial Reports:

No articles found.

Achieve Life Sciences Inc

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.